HOLLY DOOGS: Open Payments
NPI 1487433074 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 25 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $442 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Dexcom, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: JARDIANCE, Kerendia, Ozempic, CAPLYTA, MOUNJARO, OTEZLA, Dexcom G6 Transmitter, UBRELVY.
Industry payments across MO — which companies pay providers there.
